First-in-Human Implantation of a New Transcatheter Tricuspid Valve Replacement System
Research output: Contribution to journal › Journal article › Research › peer-review
Documents
- First-in-Human
Final published version, 2.67 MB, PDF document
Therapeutic options for patients with isolated severe to torrential tricuspid regurgitation have been limited. Because a surgical option is often not attractive, new catheter-based therapies are emerging. We report the first-in-human percutaneous transcatheter tricuspid valve replacement with the MonarQ system in a 75-year-old female patient with severely symptomatic torrential tricuspid regurgitation. (Level of Difficulty: Advanced.)
Original language | English |
---|---|
Article number | 101841 |
Journal | JACC: Case Reports |
Volume | 14 |
DOIs | |
Publication status | Published - 2023 |
Bibliographical note
Publisher Copyright:
© 2023 The Authors
- percutaneous, transcatheter valve therapy, tricuspid regurgitation, valve replacement
Research areas
ID: 370205442